Who owns Galectin Therapeutics?
- Ticker: GALT
- CUSIP Number: 363225202
Tip: Access positions for across all investors
Analyze quarterly positions in Galectin Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Galectin Therapeutics stock
Who bought or sold Galectin Therapeutics this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 2.1M | $5.9M | 1% | Sep 2024 |
|
| BlackRock | 1.6M | $4.4M | 100% | Sep 2024 |
|
| Affinity Asset Advisors | 1.2M | $3.3M | 100% | Sep 2024 |
|
| Advisor Group Holdings | 1.2M | $3.3M | 100% | Sep 2024 |
|
| Ikarian Capital | 1.0M | $2.8M | 100% | Sep 2024 |
|
| Geode Capital Management | 863k | $2.4M | 2% | Sep 2024 |
|
| Commonwealth Equity Services | 483k | $1.3M | 0% | Sep 2024 |
|
| Sontag Advisory | 398k | $1.1M | 0% | Sep 2024 |
|
| Geneos Wealth Management | 389k | $502k | 10% | Dec 2024 |
|
| Susquehanna International | 389k | $1.1M | -67% | Sep 2024 |
|
| Boothbay Fund Management | 292k | $804k | 100% | Sep 2024 |
|
| State Street Corporation | 251k | $690k | 9% | Sep 2024 |
|
| Northern Trust | 234k | $644k | 100% | Sep 2024 |
|
| Atria Wealth Solutions | 207k | $267k | 0% | Dec 2024 |
|
| Sovran Advisors | 186k | $214k | 100% | Dec 2024 |
|
| Retirement Guys Formula | 155k | $200k | 143% | Dec 2024 |
|
| Caption Management | 155k | $426k | 100% | Sep 2024 |
|
| Soltis Investment Advisors | 141k | $182k | 0% | Dec 2024 |
|
| Cutter & CO Brokerage | 116k | $318k | 0% | Sep 2024 |
|
| Cambridge Investment Research Advisors | 115k | $315k | 2% | Sep 2024 |
|
| Citadel Advisors | 114k | $314k | 566% | Sep 2024 |
|
| LPL Financial | 82k | $225k | -6% | Sep 2024 |
|
| Charles Schwab Investment Management | 65k | $179k | 0% | Sep 2024 |
|
| Sanctuary Advisors | 58k | $73k | -26% | Dec 2024 |
|
| Traynor Capital Management | 56k | $72k | 30% | Dec 2024 |
|
| ADAR1 Capital Management | 55k | $152k | 100% | Sep 2024 |
|
| Marshall Wace | 52k | $144k | 178% | Sep 2024 |
|
| Stratos Wealth Partners | 52k | $67k | 27% | Dec 2024 |
|
| Horizon Kinetics Asset Management | 52k | $142k | -4% | Sep 2024 |
|
| Wealth Enhancement Advisory Services | 51k | $141k | 47% | Dec 2024 |
|
| Synovus Financial Corp. | 48k | $132k | 0% | Sep 2024 |
|
| Bank of New York Mellon | 43k | $118k | -34% | Sep 2024 |
|
| Kovitz Investment Group Partners | 43k | $117k | 100% | Sep 2024 |
|
| William Blair $ Company | 38k | $104k | 0% | Sep 2024 |
|
| Millennium Management | 36k | $100k | -32% | Sep 2024 |
|
| Solutions 4 Wealth | 36k | $46k | 0% | Dec 2024 |
|
| Goldman Sachs Group | 33k | $91k | 46% | Sep 2024 |
|
| Jpmorgan Chase & Co | 31k | $84k | 161% | Sep 2024 |
|
| ExodusPoint Capital Management | 30k | $81k | 100% | Sep 2024 |
|
| Barclays | 29k | $79k | 309% | Sep 2024 |
|
| Nuveen Asset Management | 28k | $76k | 0% | Sep 2024 |
|
| Squarepoint Ops | 27k | $75k | -67% | Sep 2024 |
|
| Mariner Wealth Advisors | 27k | $73k | 0% | Sep 2024 |
|
| Gladstone Institutional Advisory | 25k | $32k | 13% | Dec 2024 |
|
| Vivaldi Capital Management | 24k | $66k | 0% | Sep 2024 |
|
| Beacon Capital Management | 24k | $31k | 0% | Dec 2024 |
|
| Bank of America Corporation | 19k | $52k | 4% | Sep 2024 |
|
| D.A. Davidson & Co. | 19k | $25k | -38% | Dec 2024 |
|
| Rhumbline Advisers | 18k | $23k | 1% | Dec 2024 |
|
| Colony | 17k | $46k | 100% | Sep 2024 |
|
| Citigroup | 15k | $41k | 229% | Sep 2024 |
|
| Wells Fargo & Company | 14k | $40k | 0% | Sep 2024 |
|
| UBS Group | 14k | $39k | 9% | Sep 2024 |
|
| SG Americas Securities | 14k | $18k | 100% | Dec 2024 |
|
| Man Group | 13k | $35k | -81% | Sep 2024 |
|
| New York State Common Retirement Fund | 13k | $16k | 0% | Dec 2024 |
|
| Inspire Advisors | 11k | $31k | 0% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 11k | $31k | 100% | Sep 2024 |
|
| Dynamic Advisors Solutions | 11k | $14k | -8% | Dec 2024 |
|
| Stock Yards Trust Company | 11k | $14k | 0% | Dec 2024 |
|
| Integrated Wealth Concepts | 10k | $28k | 0% | Sep 2024 |
|
| Simplex Trading | 9.8k | $26k | -14% | Sep 2024 |
|
| Oarsman Capital | 9.7k | $27k | 100% | Sep 2024 |
|
| CoreCap Advisors | 7.7k | $21k | 100% | Sep 2024 |
|
| Ronald Blue Trust | 7.0k | $9.0k | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 5.5k | $15k | 272% | Sep 2024 |
|
| Barrett & Company | 3.8k | $4.9k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 3.6k | $12k | 1% | Sep 2024 |
|
| Tower Research Capital | 3.3k | $9.0k | -26% | Sep 2024 |
|
| Hartland & Co | 3.0k | $8.3k | 0% | Sep 2024 |
|
| Sound Income Strategies | 3.0k | $3.8k | 0% | Dec 2024 |
|
| Legal & General Group | 2.5k | $6.8k | 0% | Sep 2024 |
|
| Activest Wealth Management | 2.0k | $2.6k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 2.0k | $5.5k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 1.5k | $4.1k | 0% | Sep 2024 |
|
| Larson Financial Group | 1.3k | $3.6k | 100% | Sep 2024 |
|
| Russell Investments | 740.00 | $2.0k | 100% | Sep 2024 |
|
| Amalgamated Bank | 705.00 | $2.0k | 0% | Sep 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 600.00 | $774.000000 | 0% | Dec 2024 |
|
| Global Retirement Partners | 250.00 | $323.000000 | 0% | Dec 2024 |
|
| FMR | 182.00 | $500.991400 | 100% | Sep 2024 |
|
| CWM | 170.00 | $0 | 100% | Sep 2024 |
|
| Salem Investment Counselors | 167.00 | $215.997800 | 0% | Dec 2024 |
|
| Sterling Capital Management | 38.00 | $105.001600 | 100% | Sep 2024 |
|
| FNY Investment Advisers | 6.00 | $0 | 100% | Dec 2024 |
|
Who sold out of Galectin Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Summit Trail Advisors | Sep 2024 | 20k | $55k |
| Alpine Partners VI | Jun 2024 | 20k | $44k |
| Connor, Clark & Lunn Investment Management | Jun 2024 | 17k | $38k |
| Virtu Financial | Jun 2024 | 11k | $25k |